S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GRF Eagle Capital Growth Fund Inc

9.98

0.00 (0.00%)

Pre Market

Last Updated: 20:09:34

Delayed by 15 minutes

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Eagle Capital Growth Charts.

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Eagle Capital Growth Charts.

Eagle Capital Growth Fund Inc News

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)
Saturday 1 March 2025 (4 days ago) • Edgar (US Regulatory)

Form N-CEN - Annual Report for Registered Investment Companies
Saturday 1 March 2025 (4 days ago) • Edgar (US Regulatory)

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
Tuesday 14 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 December 2024 (3 months ago) • Edgar (US Regulatory)

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Wednesday 20 November 2024 (3 months ago) • GlobeNewswire Inc.

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
Tuesday 19 November 2024 (3 months ago) • Business Wire

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Tuesday 29 October 2024 (4 months ago) • GlobeNewswire Inc.

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Tuesday 22 October 2024 (4 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (5 months ago) • Edgar (US Regulatory)

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
Thursday 3 October 2024 (5 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 September 2024 (6 months ago) • Edgar (US Regulatory)

More Eagle Capital Growth Fund Inc News Articles

Gold vs US Dollar

Newcrest Mining

Commonwealth Bank Of Aus...

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions